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two phase culture system that enables the distinction between the 
expansion of early and late progenitors. In the first phase (3 
weeks), the cultures were supplemented with both TEPA and 
cytokines (FLt3, SCF, TPO, IL-6). In the second phase (addition- 
al 5-7 weeks) the cultures were supplemented with cytokines 
alone, in the absence of TEPA. Late progenitors (CD34+ and 
CFUc) as well as early progenitor cells (CD34+CD38-, 
CD34+Lin-(CD38, 33, 14, 15, 61, 41, 3, 4, 19), CD34+38-HLA- 
DR-) were measured at the termination of the treatment phase 
(week 3) as well as at different intervals during the long-term assay 
phase. After the first phase (3w), TEPA cultures contained signifi- 
cantly higher percentages of early progenitors (21% CD34+38- 
+/- 3.8; 7.0% CD34+Lin- +/-1.9, 1.5%+/-0.5 CD34+38-HLA- 
DR, n=9-) as compared to the control, only cytokine treated cul- 
tures (2.6% CD34+38- +/ 1, 0.9% CD34+Lin- +/-0.3, 0% 
CD34+38-HLA-DR- n=9 ). At the same time, no differences were 
noticed in the late progenitors (TNC, CFUc and CD34+ cells) 
between control and TEPA cultures. Fold expansion of CD34+ 
ceils in both control and treated cultures was in the range of 10-40 
(N=6) folds. After the second phase (additional 5-7w) in the 
TEPA pre-treated cultures, CD34+ cells expanded by 370-1320 
folds (N=6) whereas no CD34+ cells could be recovered in control 
cultures. CFUc expansion i  TEPA pre-treated cultures was by 20 
to 30 folds (n=6) higher than in the control cultures. These results 
indicated that the chelator enabled preferential proliferation of 
early progenitors during the first three weeks. At this stage, no 
positive or negative ffect on the expansion of late progenitors and 
TNC was obsmwed. These early progenitors continued to prolif- 
erate and differentiate during the TEPA free phase and supported 
the extensive xpansion of late progenitors during the long term 
cultures.The chelator based method of three weeks ex vivo expan- 
sion, which resulted in a cell graft enriched in early progenitors 
increased by 10 told the engraftment in SCID mice. We plane to 
test the safety and efficacy of such a graft in clinical cord blood 
transplantation. 
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THE PRESENCE CXCR4 ON CD34+ CELLS WAS ASSOCIATED WITH 
THE EFFECTIVENESS OF G-CSF PBPC MOBILIZATION 
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The presence of CXCR4 on CD34+ cells plays a role in 
hematopoietic progenitors rafficking" and reflects the stage of 
these cells dif ferentiat ion. The most primitive cells are 
CXCR4 strongly positive than they loose this epitope and 
gain it again while become DR positive. Therefore, we inves- 
tigated the proportions of CXCR4+ and DR+ cells among 
CD34+ cells in ninety G-CSF mobilized leukapheresis prod- 
ucts (PBPC) obtained from fifty eight volunteer, healthy 
donors and in thirty one bone marrow harvests (BM) for allo- 
geneic grafting'. Marrow transplant materials differed from 
PBPC with respect to the proport ions of CD34+ cells 
(0.91%+-0.07 vs 0.64%+-0.04, p=0.001) which were, however, 
to the similar proport ion DR negative (14.15%+-1.81 vs 
13.89%+-1.44). Looking at the co-expression of CXCR4 and 
DR on CD34+ cells, it was found that PBPC CD34+ cells 
were more frequently CXCR4-DR+ as compared to marrow 
(48.42%+-2.45 vs 39, 34%+-4.38, p=0.05). Marrow CD34+ 
cells were more frequently CXCR4+ than those in PBPC 
(62.47%+-4.09 vs 50.91%+-2.47, p=0.02). PBPC preparations 
were richer in CD34+ cells if the latter cells were in higher 
proportions CXCR4 negative (r=0.45, p=0.00001), in variance, 
marrows harvested for transplantation contained more CD34+ 
cells if they were CXCR4+ (r=0.34, p=0.06) It may be con- 
cluded that the presence of CXCR4 on CD34+ ceils influ- 
enced the yield of transplant material in hematopoietic pro- 
genitors. The coexopression of CXCR4 on CD34+ cells made 
the marrow harvest richer in hematopoietic progenitors but 
the content of CD34+ cells in G-CSF mobilized PBPC signif- 
icantly depended on the presence of CD34+ cells lacking 
CXCR4. 
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SIBLING DONOR CORD BLOOD (SDCB) BANKING AND TRANSPLAN- 
TATION FOR CHILDREN WITH SICKLE CELL ANEMIA AND THA- 
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Sickle cell anemia nd thalassemia are two genetic diseases with 
a worldwide incidence. Vffhile current reatment protocols for 
these patients have improved their lives, hematopoctic stem cell 
(HSC) transplantation is the only current reatment that offers a 
promise of cure. The donor for a HSC transplant is most often an 
HLA matched sibling. Recent evidence suggests that umbilical 
cord blood (CB), obtained from a sibling, may provide an impor- 
tant source of HSCs for these transplants. \Ve have developed a
National SDCB Banking program to provide a resource to evalu- 
ate CB transplantation. Our bank has fascilitated the collection of 
over 200 CB samples for families who already had a child with 
sickle cell anemia or thalassemia.. The volume of CB (average 100 
ml) collected and the nucleated cell counts were sufficient o pro- 
vide at least 2.5x107 cells/kg recipient weight in 85% of the cases. 
Taken together with recent results reported by NETCORD, a 
total of 44 children with henroglobinopathies (33 thalassemia, 11 
sickle cell anemia) have been transplanted with HLA matched 
SDCB. 85% appear to have been cured. The remaining children 
failed to engraft and had a return of disease. Minimal GVHD was 
noted. None of the children died as a result of the transplant. 
~eVhile acommon transplant protocol was not followed, our results 
suggest that modification of the conditioning regimen and provid- 
ing a critical nucleated cell dose will enhance ngraftment and 
improve outcome. We conclude that SCDB banking should be 
available to all families who currently have a child with sickle cell 
anemia or thalassemia. A prospective study to determine the opti- 
mal regime for SDCB transplantation is currently underway. 
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OPTICAL IMAGING OF EARLY POST-TRANSPLANT DESTINY OF BONE 
MARROW PROGENITOR CELLS IN MICE 
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Use of non-invasive isualization techniques to follow up the 
destiny of transplanted hematopoietic stem cells provide a reliable 
tool for investigation of the processes of transplant engraftment 
and reconstitution of hematopoiesis. Bone marrow, harvested 
from C57BL/6-Ly.1 donor mice, was negatively sorted for differ- 
entiation determined c lls. The obtained enriched population of 
bone marrow precursor cells (BMPC) was stably transfected with 
ecotropic retrovirus carrying TK-dmDHFR and GFP-Luc 
chimeric genes. Transfected cells were positively selected on 
FACSVantage using GFP-expression signal. 10A4 BMPC were 
reinfused as a rescue of lethally irradiated C57BL/6-Ly.2 recipient 
mice. D-lueiferin was administered either in vivo, immediately 
post-transplant, or ex vivo, directly to the BMPC, in two animal 
groups: Bioluminescent imaging (BLI) was started in 5 minutes 
after the BMPC. For the follow up studies, d-luciferin was admin- 
istered I.V. to all animal groups. Control group included irradiat- 
ed animals without BMPC support. BLI revealed a weak, but dis- 
tinctive signal accumulation in the projection of lungs and 
mediastinum with animals in supine position. Dilution of BMPC 
local concentration resulted in disappearance of any detectible sig- 
nal between hours 36 and 60. Further obsmwation demonstrated 
BMPC localization to the final hematopoietic sites. Higher signal 
was registered in the animals inoculated with the ex vivo d- 
lueiferin preineubated BMPC. No specific signal was identified in 
the control group. ~/Veak sources of photons associated with the 
projection of open skin/mucosa areas corresponded to the subin- 
flared thermal photon background. Early migration of a small 
nmnber of stem cells can be efficiently monitored using highly 
sensitive bioluminescence approach. Systemic BMPC dose lower 
limits for sensitivity of BLI registration were identified. Triple 
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